By this, the extension drilling would need to be turning up 4 or 5 times the exisiting resource to start makingng it viable? And these results are not even hinting in that ballpark.
So this really the crux of my challenge to ADV, to quote this specific announcement, "The continued success of our extension and exploration drilling".
To find lithium in early holes of a new program is a success, but their messure of success after this many years is still to have minor hits which marginally increases an already way too small resource?
If these results indicate they are succeeding with their goals, what are those goals then?
Yes they hit more lithium, yes it extends the know dip of the ore body, but what is the big picture?
While the company uses investor money to continue operations, both retail and institutional money, what is their plan of returning that capital to investors and then some?
By quote, they are succeeding in their plan.
The question is, what is that plan and who does it end up rewarding?
They need to be reading this and addressing these questions because I don't another cap raise could even be viable once the 6million is gone, and that is a massive shame considering the potential of the ground.
- Forums
- ASX - By Stock
- ADV
- Ann: High-Grade Lithium Results Support Growth at North Aubry
Ann: High-Grade Lithium Results Support Growth at North Aubry, page-16
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADV (ASX) to my watchlist
(20min delay)
|
|||||
Last
13.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.439M |
Open | High | Low | Value | Volume |
13.5¢ | 13.5¢ | 13.0¢ | $515 | 3.953K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 117347 | 13.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
14.0¢ | 71428 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 3201255 | 0.003 |
21 | 33473529 | 0.002 |
10 | 17528549 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 12395196 | 16 |
0.005 | 6855445 | 11 |
0.006 | 6847500 | 13 |
0.007 | 3792287 | 8 |
0.008 | 6107932 | 8 |
Last trade - 12.04pm 25/11/2024 (20 minute delay) ? |
Featured News
ADV (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online